Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 208

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 208
---
 private medical device and technology
companies, including Quescon Consultants since 2012 and Momentis since 2016. Dr. Blumenfeld holds a B. A. Sc in Engineering Physics, an
M. A. in Molecular Physics and a Ph. D. in Molecular Physics from the University of Toronto. We believe that Dr. Blumenfeld’s industry
experience qualify him to serve on our board of directors.

Maya
Netser. She
previously served as COO and board member of Voyager Labs, an AI-based technology company that enables organizations to extract granular
actionable insights from unstructured data. Ms. Netser also has over 20 years of corporate and IP legal experience. From 2006-2015, she
was a Partner at the law firm Herzog, Fox, and Neeman, where she established and led the firm’s technology practice, growing her
team to 30 lawyers. Ms. Netser earned both her LL. B and MBA from Tel Aviv University. We believe that Ms. Netser’s industry and
operating experience qualify her to serve on our board of directors.

Alan Adlerhas served
as a member of our board of directors since 2018. Mr. Adler served as a chairman of the board of directors and chief executive officer
of Israeli-based Oridion Systems Ltd, from 2004 until the company was acquired by Medtronic plc, f/k/a Covidien (NYSE: MDT), in 2012.
Prior to that, he gained over 14 years of experience as a principal at McKinsey & Company and, afterwards, as a senior partner at
Evergreen Venture Partners, an Israeli venture capital group. Mr. Adler currently serves as a member of the board of directors of a number
of private technology and life science companies, including Izun Pharmaceuticals Corporation since October 2018, Renalguard Solutions
Inc. since March 2017, Scopio Labs Inc. since April 2018, Pardes Institute of Jewish Studies since 2012, and Shalem College since 2013.
Mr. Adler holds a B. Sc. in Mathematics from Rensselaer Polytechnic Institute and an MBA with honors from Stanford University. We believe
that Mr. Adler’s financial and industry experience qualify him to serve on our board of directors.

David M. Milch, M. D. has
served as a member of our board of directors since March 2022. Dr